We are live on ! Find out more
BBA

Baker Bros. Advisors Portfolio holdings

AUM $17.4B
1-Year Est. Return 131.5%
This Fund
S&P 500
This Quarter Est. Return
+10.86%
1 Year Est. Return
+131.5%
3 Year Est. Return
+336.81%
5 Year Est. Return
+553.16%
10 Year Est. Return
+4,134.93%
AUM
$5.06B
AUM Growth
–
Cap. Flow
+$4.02B
Cap. Flow %
79.47%
Top 10 Hldgs %
79.91%
Holding
75
New
67
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
PCYC
PHARMACYCLICS INC
PCYC
+$880M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$674M
3
GHDX
Genomic Health, Inc.
GHDX
+$448M
4
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
+$420M
5
INCY icon
Incyte
INCY
+$324M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 39.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LGND icon
51
Ligand Pharmaceuticals
LGND
$5.77B
$2.75M 0.05%
+117,660
New +$2.12M
WINT
52
DELISTED
Windtree Therapeutics Inc
WINT
$2.31M 0.05%
+108,473
New +$2.67M
ENTA icon
53
Enanta Pharmaceuticals
ENTA
$362M
$2.21M 0.04%
+125,000
New +$2.44M
ARQL
54
DELISTED
Arqule Inc
ARQL
$2.04M 0.04%
+879,805
New +$2.37M
CYTR
55
DELISTED
CytRx Corp
CYTR
$2M 0.04%
+166,667
New +$2.46M
RCPT
56
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$1.99M 0.04%
+100,000
New +$1.69M
GERN icon
57
Geron
GERN
$898M
$1.5M 0.03%
+1,058,000
New +$1.15M
FOLD
58
DELISTED
Amicus Therapeutics
FOLD
$1.2M 0.02%
+515,072
New +$1.58M
TSRO
59
DELISTED
TESARO, Inc.
TSRO
$1.02M 0.02%
+31,218
New +$964K
ALBO
60
DELISTED
Albireo Pharma Inc
ALBO
$961K 0.02%
+7,663
New +$797K
OSUR icon
61
OraSure Technologies
OSUR
$273M
$945K 0.02%
+243,467
New +$1.09M
APEN
62
DELISTED
Apollo Endosurgery, Inc.
APEN
$880K 0.02%
+2,597
New +$976K
EPZM
63
DELISTED
Epizyme, Inc
EPZM
$563K 0.01%
+20,000
New +$514K
TCRT icon
64
Alaunos Therapeutics
TCRT
$4.64M
$536K 0.01%
+1,695
New +$471K
CBST
65
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$241K ﹤0.01%
+5,000
New +$246K
ARDM
66
DELISTED
ARADIGM CORPORATION
ARDM
$16K ﹤0.01%
+100,000
New +$16K
1 2
3

Similar funds

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return

Baker Bros. Advisors's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Baker Bros. Advisors, which disclosed 75 positions worth $5.06B. Its ten largest holdings account for 80% of the portfolio.

Its largest position is PHARMACYCLICS INC: 10,771,138 shares worth $856M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets.

  • Baker Bros. Advisors's largest Q2 2013 buy was PHARMACYCLICS INC: 10,771,138 shares worth $856M.
  • Baker Bros. Advisors's ten largest holdings make up 80% of its $5.06B portfolio in Q2 2013.
  • Baker Bros. Advisors disclosed 75 positions in Q2 2013, its first 13F filing on record.

Based on Baker Bros. Advisors's 13F filing for Q2 2013, filed 14 Aug 2013.